Ulipristal acetate tablets

作者: Celine Gnakamene , Erin Gainer , Denis Gicquel , Helene Guillard , Marianne Henrion

DOI:

关键词:

摘要: The invention relates to a pharmaceutical tablet for oral administration comprising ulipristal acetate together with the following excipients: at least one diluent in an amount of 50 98.5 wt %, binding agent 0 10 disintegrating 0.5 and lubricant %.

参考文章(37)
Pedro A Orihuela, Ulipristal, a progesterone receptor antagonist as a contraceptive and for the treatment of uterine fibroids. Current opinion in investigational drugs. ,vol. 8, pp. 859- 866 ,(2007)
Lee Sm, Evans Mf, Dunn S, Levonorgestrel versus the "Yuzpe" regimen. New choices in emergency contraception. Canadian Family Physician. ,vol. 45, pp. 629- 631 ,(1999)
Ramarao Chatlapalli, Arwinder Nagi, Mohamed K. Ghorab, Rolland W. Carson, Shamim A. Hasan, Micronized tanaproget and compositions containing same ,(2006)
Paul J Sheskey, Marian E Quinn, Raymond C Rowe, Handbook of Pharmaceutical Excipients ,(1994)
Herbert A. Lieberman, Leon Lachman, Joseph L. Kanig, The Theory and Practice of Industrial Pharmacy ,(1970)
Katalin Komandi, Paul F. A. Van Look, Laszlo Nemes, Zsolt Szabo, Illesne Balogh, Dosage regimen and pharmaceutical composition for emergency contraception ,(2002)
Arwinder S. Nagi, Mohamed Ghorab, Shamim Hasan, Ramarao S. Chatlapalli, Rolland W. Carson, Compositions containing micronized tanaproget prepared by wet granulation ,(2006)